Emmis Acquisition (EMIS) vs Korro Bio (KRRO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Emmis Acquisition is the larger company by market cap ($162.0 million vs $154.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMIS | KRRO |
|---|---|---|
| Share price | $10.27 | $10.49 |
| Market cap | $162.02M | $154.47M |
| 1-day change | 0.00% | +7.48% |
| YTD return | +3.22% | +30.96% |
| 1-year return | — | -78.49% |
| 5-year return | — | -97.05% |
| EPS (TTM) | — | $-10.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.27 | $55.89 |
| 52-week low | $9.90 | $5.20 |
| Distance from 52-week high | 0.00% | -81.23% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +92.56% |
| Average volume | 13.89K | 148.67K |
| Shares outstanding | 11.94M | 14.73M |
| Employees | — | 57 |
| Sector | Financial Services | Healthcare |
| Industry | Shell Companies | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Emmis Acquisition in Financial Services and Korro Bio in Healthcare.
About Emmis Acquisition
EMIS stock →Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Financial Services · Shell Companies
About Korro Bio
KRRO stock →Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia.
Healthcare · Biotechnology · 57 employees
EMIS vs KRRO FAQ
Which is bigger, Emmis Acquisition or Korro Bio?
Emmis Acquisition (EMIS) is larger, with a market capitalization of $162.02M compared with $154.47M for Korro Bio (KRRO).
Are Emmis Acquisition and Korro Bio in the same industry?
No. Emmis Acquisition is in the Financial Services sector, while Korro Bio is in Healthcare.